Time for Clinical Dopamine Transporter Scans in Parkinsonism?: Not DAT Yet
- PMID: 38759140
- PMCID: PMC11175627
- DOI: 10.1212/WNL.0000000000209558
Time for Clinical Dopamine Transporter Scans in Parkinsonism?: Not DAT Yet
Conflict of interest statement
D.G. Di Luca has no disclosures; J.S. Perlmutter has served as Director of Medical and Scientific Advisory Committee of the Dystonia Medical Research Foundation, Chair of the Scientific Advisory Committee of the Parkinson Study Group (2020–2023), Chair of the Professional Ethics and Standards Committee of the Huntington Study Group, past member of the Scientific Advisory Board of the APDA (2016–2023), Chair of the Scientific and Publication Committee for ENROLL-HD (received honoraria), and is a member of the Education Committee of the Huntington Study Group (received honoraria), is an employee of Washington University in St. Louis, has received honoraria from CHDI, Huntington Study Group, Parkinson Study Group, Beth Israel Hospital (Harvard group), U Illinois in Chicago; Boston University, Georgetown University, St Lukes Hospital, has received payment for travel expenses from Dystonia Medical Research Foundation, is supported by the following NIH grants: NIH (NCATS, NINDS, NIA): NS103957, NS107281, RF1NS075321, RO1NS134586, RO1NS103957, NS097437, U54NS116025, U19 NS110456, NS097799, NS075527, ES029524, NS109487, R61 AT010753, RO1NS118146, UG3MH126861, NS124738, R01AG065214, NS124789, has received support from the Michael J Fox Foundation, Barnes-Jewish Hospital Foundation (Elliot Stein Family Fund and Parkinson disease research fund), American Parkinson Disease Association (APDA) Advanced Research Center at Washington University, Missouri Chapter of the APDA, Paula and Rodger Riney Fund, Jo Oertli Fund, Huntington Disease Society of America, Murphy Fund, Fixel Foundation, N. Grant Williams Fund, Pohlman Fund, CHDI and Prilenia. He is also co-director for the Dystonia Coalition, which has received the majority of its support through the NIH (grants NS116025, NS065701 from the National Institutes of Neurological Disorders and Stroke TR 001456 from the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences), and has provided medical-legal consultation regarding Parkinson disease in 2022 and tremor in 2023. Go to
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources